BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Opioid Overdose readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Opioid Overdose\, fro
 m ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06251609-8925@assetmemo.bio
DTSTAMP:20261121T005350Z
DTSTART;VALUE=DATE:20290228
DTEND;VALUE=DATE:20290301
SUMMARY:Naloxone (Narcan): Phase 2 readout est. (NCT06251609)
DESCRIPTION:Naloxone (Narcan)\, phase 2\, Opioid Overdose.\nStudy: Naloxone
  for Opioid Associated Out of Hospital Cardiac Arrest\nEstimated primary c
 ompletion: 28 February 2029. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/naloxone-narcan#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT06251609
URL:https://assetmemo.bio/drug/naloxone-narcan#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
